Gain‐of‐function mutations in NLRC4 cause potentially lethal periodic fever syndromes that are characterized by high circulating IL‐18 levels and increased risk for the development of macrophage activation syndrome (MAS).65, 66. This evidence concerns the gene NLRC4 and macrophage activation syndrome.